Results 261 to 270 of about 390,832 (276)

The re-emergence of natural products for drug discovery in the genomics era

Nature Reviews Drug Discovery, 2015
RuAngelie Edrada-Ebel, Ronald J Quinn
exaly  

Key issues surrounding the health impacts of electronic nicotine delivery systems (ENDS) and other sources of nicotine

Ca-A Cancer Journal for Clinicians, 2017
Jeffrey M Drope, Zachary Cahn, Michal Stoklosa   +2 more
exaly  

Targeted Therapy of Cancer: New Prospects for Antibodies and Immunoconjugates

Ca-A Cancer Journal for Clinicians, 2006
David M Goldenberg
exaly  

Endarterectomy for symptomatic carotid stenosis in relation to clinical subgroups and timing of surgery

Lancet, The, 2004
Peter M Rothwell
exaly  

The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroups

Nature, 2012
Christina Curtis, Sohrab P Shah, Suet-feung Chin   +2 more
exaly  

Atypical Teratoid/Rhabdoid Tumors Are Comprised of Three Epigenetic Subgroups with Distinct Enhancer Landscapes

Cancer Cell, 2016
Serap Erkek, Marc Zapatka, Kornelius Kerl   +2 more
exaly  

Novel mutations target distinct subgroups of medulloblastoma

Nature, 2012
Giles W Robinson, Matthew Parker, Xiang Chen   +2 more
exaly  

Ferguson Plant Products

Ca-A Cancer Journal for Clinicians, 1972
exaly  

Novel molecular subgroups for clinical classification and outcome prediction in childhood medulloblastoma: a cohort study

Lancet Oncology, The, 2017
Stephen Crosier, Debbie Hicks, Rebecca M Hill   +2 more
exaly  

Recurrence patterns across medulloblastoma subgroups: an integrated clinical and molecular analysis

Lancet Oncology, The, 2013
Vijay Ramaswamy, Marc Remke, Eric Bouffet   +2 more
exaly